MMMM D, YYYY

Clinical Study Results Sanofi Pharma, including Sanofi Genzyme

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter R

Generic Name Trade Name Condition Study Code Study Name ACCESS TO STUDY / PROTOCOL Access to results
RABBIT ANTI-THYMOCYTE GLOBULIN Thymoglobulin Myelodysplastic Syndrome ThymoHEM01206 RISE NCT00542828
RAMIPRIL Triatec Heart diseases HOE498_3501 FOCUS NCT00268619
RAMIPRIL Triatec Atherosclerosis HOE498_4099 HOPE NCT01053910
RAMIPRIL Triatec Glomerulonephritis HOE498_6015 NA NCT00437463
RAMIPRIL Triatec Hypertension HOE498_3E03 PHARAO NCT00325806
RAMIPRIL Triatec Coronary Artery Disease RAMIP_L_03123 HOPETips NCT03099213
RAMPIRIL + FELODIPINE Triapin Hypertension RAMFE_L_03420 NA NCT00841880
RAMPIRIL + FELODIPINE Triapin Hypertension RAMIP_L_01961 RAFE HELP NCT00507845
RASBURICASE Elitek, Fasturtec Hyperuricemia ACT5080 NA NCT00290992
RASBURICASE Elitek, Fasturtec Hyperuricemia ARD5290 NA NCT00631579
RASBURICASE Elitek, Fasturtec Tumor lysis syndrome EFC4978 NA NCT00230178
RASBURICASE Elitek, Fasturtec Cancer, Hyperuricemia EFC4978 NA NCT00230178
RASBURICASE Elitek, Fasturtec Hyperuricemia EFC4983 GRAAL2 NCT00664144
RASBURICASE Elitek, Fasturtec Hyperuricemia EFC5339 NA NCT00230217
RASBURICASE Elitek, Fasturtec Tumor lysis syndrome L_8637 NA NCT00651911
RASBURICASE Elitek, Fasturtec Hematologic neoplasms L_8720 NA NCT00563771
RASBURICASE Elitek, Fasturtec Hyperuricemia L_9436 NA NCT00302653
RASBURICASE Elitek, Fasturtec Hyperuricemia RASBU_L_00351 NA NCT00607152
RHO-KINASE INHIBITOR Not marketed Erectile Dysfunction ACT10775 RHOKET EudraCT: 2009-009936-56
RHO-KINASE INHIBITOR Not marketed Microvascular Coronary Artery Disease ACT14656 NA NCT03236311
RHO-KINASE INHIBITOR Not marketed Chronic Kidney Disease TDR12446 NA NCT01485900
RIFAPENTINE Priftin Tuberculosis INT12291 NA NCT01690403
RILUZOLE Rilutek Amyotrophic Lateral Sclerosis RIL_CA1_401 CARE NCT00542412
RILUZOLE Rilutek Amyotrophic Lateral Sclerosis RIL_DE1_201 NA NCT00277602
RIFERMINOGENE PECAPLASMID Not marketed Critical limb ischemia EFC6145 TAMARIS NCT00566657
RIMONABANT Acomplia Obesity ACT3801 NA NCT00481975
RIMONABANT Acomplia Obesity DRI5747 NA NCT00459004
RIMONABANT Acomplia Obesity EFC4733 RIO-EUROPE NCT00386061
RIMONABANT Acomplia Obesity EFC4735 RIO-LIPIDS NCT00029835
RIMONABANT Acomplia Obesity EFC4736 RIO-DIABETES NCT00029848
RIMONABANT Acomplia Obesity EFC4743 RIO-NORTH AMERICA NCT00029861
RIMONABANT Acomplia Smoking Cessation EFC4796 STRATUS-WW NCT00459173
RIMONABANT Acomplia Obesity EFC4798 CIRRUS NCT00458718
RIMONABANT Acomplia Diabetes, Type 2 EFC5593 ARPEGGIO EudraCT: 2005-001613-17
RIMONABANT Acomplia Obesity Dyslipidemia EFC5823 ADAGIO EudraCT: 2005-000807-33
RIMONABANT Acomplia Obesity EFC5827 STRADIVARIUS NCT00124332
RIMONABANT Acomplia Obesity EFC6001 RIO-ASIA NCT00325546
RIMONABANT Acomplia Obesity RIMON_R_00961 PRADO NCT00405808
RISEDRONATE SODIUM Actonel Osteoporosis, Postmenopausal EFC6063 (HMR4003B/4003) NA NCT00358176
RISEDRONATE SODIUM Actonel Osteoporosis, Postmenopausal EFC6064 NA NCT00353080
RISEDRONATE SODIUM Actonel Osteoporosis HMR4003B_3507 OSMAUSE EudraCT: 2005-005598-30
RISEDRONATE SODIUM Actonel Osteoporosis HMR4003B_4001 IMPACT NCT00268632
RISEDRONATE SODIUM Actonel Osteoporosis, Postmenopausal HMR4003F/4001 NA NCT00402441
RISEDRONATE SODIUM Actonel Osteoporosis, Postmenopausal RISED_L_01930 SOLID NCT00460733
RISEDRONATE SODIUM Actonel Bone Diseases HMR4003B_2501 NA NCT00351091
RISEDRONATE SODIUM Actonel Bone Diseases HMR4003B_4027 ACTIVATE NCT00616694
RISEDRONATE SODIUM Actonel Bone Diseases HMR4003B_4031 POWER NCT00549068
RISEDRONATE SODIUM Actonel Bone Diseases HMR4003B_4033 NA NCT00790101
RISEDRONATE SODIUM Actonel Bone Diseases HMR4003B_4034 OPTAMISE EudraCT: 2004-002317-37
RISEDRONATE SODIUM Actonel Bone Diseases HMR4003B_4035 NA NCT00549965
RISEDRONATE SODIUM Actonel Bone Diseases HMR4003B_4036 NA NCT00453492
RISEDRONATE SODIUM Actonel Bone Diseases RISED_L_01054 NA NCT00632216
RISEDRONATE SODIUM Actonel Bone Diseases RISED_L_01686 ROSPA NCT00544180
ROMILKIMAB Not marketed Idiopathic Pulmonary Fibrosis DRI11772 ESTAIR EudraCT: 2014-003933-24
ROMILKIMAB Not marketed Systemic Sclerosis ACT14604
EudraCT: 2016-001028-80


References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted